Education
About Us
Working with TipRanks
Follow Us
Infant Bacterial Therapeutics AB (DE:9IB)
FRANKFURT:9IB
Earnings Data
Report Date
May 06, 2026TBA (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.13Last Year’s EPS
-0.12Same Quarter Last Year
Based on 0 Analysts Ratings
Infant Bacterial Therapeutics AB (DE:9IB) Earnings, Revenues Date & History
DE:9IB Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:9IB Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 06, 2026 | €4.31 | €4.63 | +7.42% |
Nov 13, 2025 | €5.30 | €4.70 | -11.32% |
Aug 20, 2025 | €4.71 | €4.73 | +0.42% |
May 07, 2025 | €5.47 | €5.63 | +2.93% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Infant Bacterial Therapeutics AB (DE:9IB) report earnings?
Infant Bacterial Therapeutics AB (DE:9IB) is schdueled to report earning on May 06, 2026, TBA (Confirmed).
What is Infant Bacterial Therapeutics AB (DE:9IB) earnings time?
Infant Bacterial Therapeutics AB (DE:9IB) earnings time is at May 06, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Infant Bacterial Therapeutics AB stock?
The P/E ratio of Infant Bacterial Therapeutics AB is N/A.
What is DE:9IB EPS forecast?
DE:9IB EPS forecast for the fiscal quarter 2026 (Q1) is -0.13.